Editorial Board

Vickie-Goff

Victoria Goff
Editor-in-Chief

Vice President,
Regulatory Affairs, Mundipharma, UK

Victoria graduated from university with a BSc in Chemistry with analytical science and worked in quality control and pharmaceutical technical development before moving into regulatory CMC. She joined the Mundipharma regulatory team with responsibility for providing regulatory strategy for marketed products, labelling and CMC across the portfolio. From 2025, she stepped into the role of leading the global regulatory function for Mundipharma.

Sobhey Nassar 2025

Sobhey Nassar
Deputy Editor

Head of Regulatory Affairs,
UK, Ireland & Nordics, Bausch + Lomb, UK

Sobhey has extensive industry experience, having worked in manufacturing site, regional and global roles, and has broad product expertise in Rx, OTC and food supplements. He currently manages a portfolio of ophthalmic products authorised in the UK, Ireland and Nordics region and is actively involved with trade association groups such as PAGB and ABHI. He joined TOPRA in 2006 and the journal’s Editorial Board in 2014. 

Mockup-for-RR

Are you a TOPRA member and interested in joining the Regulatory Rapporteur Editorial Board?

Responsibilities include:

  • Identifying new topics for inclusion in the journal
  • Commissioning / peer reviewing articles
  • Facilitating information exchange with other members
  • Conducting interviews with industry experts
  • Amplifying the profile of Regulatory Rapporteur within the industry

If you’d like to apply, please contact publications@topra.org and share your CV.

RR_image_400x400px_Jack Bacon

Jack Bacon

Founder and Principal Consultant,
MedTech Integrity Ltd, UK

Jack is a medical device expert in quality assurance and regulatory affairs, and Founder of MedTech Integrity Ltd, specialising in ISO 13485, EU MDR, UKCA compliance and SaMD regulation. He supports medical device manufacturers across all device classifications with robust quality systems, technical documentation and post-market strategy, bringing practical expertise to the profession.

Joan Boren

Senior Director, Regulatory Affairs,
AstraZeneca, UK

Joan provides regulatory strategy and advice on
global product development and marketing
strategies, being involved in interactions with
regulatory authorities worldwide to agree on a
successful pathway. His area of focus is on
oncology products, with expertise in ATMP
and biologics. He holds a PhD in biochemistry
and molecular biology.

Screenshot_20250228_171715_Gallery_996x996

Dr Angeles Escarti-Nebot

Global Division Head Regulatory Affairs,
QbD Group

With over 15 years’ experience in academic research, consultancies and industry, Angeles brings a wealth of knowledge in regulatory strategy across the product lifecycle. She is particularly focused on the convergence of data, AI and innovation. She holds a PhD in Molecular and Cellular Biology, a BA in Pharmacy, and Master’s degrees in Clinical Genetics and Neuropharmacology.

Kornelia Grein

Veterinary Medicines Consultant,
KGVetMedConsultancy, Germany

Kornelia Grein has an extensive career which includes 20 years in management positions with responsibilities for veterinary medicines at the EMA. She currently provides services to the animal health industry and other organisations concerned with the development and authorisation of veterinary medicines as an independent consultant.

RR_image_400x400px_Asha

Dr Asha Kattige

Technical Head (UK) and Principal Consultant,
Scendea, UK

Asha is a senior regulatory affairs leader with 25+ years of global pharmaceutical industry experience spanning multiple therapeutic areas including asthma, COPD, neurodegenerative disorders, diabetes, and oncology. She has particular expertise across small molecules, biologics, proteins and peptides, and radiopharmaceutical therapies.

Leah Kleylein

Regulatory Intelligence Associate Director, Accenture, US

Leah’s function is Life Sciences and Regulatory Intelligence within Accenture’s Life Sciences practice, with over 20 years of experience. Leah monitors the Life Sciences regulatory environment for regulations, innovations and trends. Leah previously worked for global pharmaceutical companies in regulatory and has deep technical experience in electronic submission standards.

James McCormick

Senior Director, Regulatory Affairs,
PPD Global Ltd, UK

James is a Senior Director in regulatory affairs and with more than 40 years of experience in research and development, he supports clients across the full spectrum of regulatory development. He mentors staff and clients with the delivery of their development strategies and maximisation of the global market.

Sarah Milner

Sarah Milner

Director of Medical Writing
ELIQUENT Life Sciences Ltd

Sarah is a Director of Medical Writing, experienced in coordinating and authoring key documents intended for global procedures, and literature published in highly acclaimed medical journals. She is a member of the editorial team for the EMWA journal. Her specialties include paediatrics and rare disease.

 

Ash Ramzan

Principal Consultant and Founder,
Woodley BioReg Ltd, UK

Ash has expertise in the manufacture,
testing, release and global registration of
pharmaceutical and biopharmaceutical
products, including lifecycle management/
maintenance and product conformance.
He also has specialist expertise in
vaccines and biological products,
and is a member of the MHRA/BP Working Party on biosimilars.

RR_image_400x400px_Deep

 Deep Shah

Global Regulatory Leader,
Sana Biotechnology, Inc.

Deep is an influential biotech leader and regulatory affairs expert with over 10 years of experience in cell and gene therapies.

Currently a Global Regulatory Leader at Sana, he specialises in risk-informed drug development, strategic innovation, and pioneering next-generation cell therapies for T1D.

 

RR_image_400x400px

Laura Taylor

Regulatory and Quality Consultant
Advena

Laura is a Regulatory and Quality Consultant at Advena Medical, specialising in medical devices with expertise in quality management systems and medical writing. She has extensive experience supporting CE marking for devices up to Class IIb implantable, and supporting Notified Body and MDSAP audits. Laura holds an MSc in Strategic Quality Management and is a certified ISO 13485 lead auditor.

Marie Uguen

Senior Vice President, Regulatory Affairs and Quality Assurance, SparingVision, France

Marie leads on regulatory strategy for SparingVision’s ocular diseases ATMP pipeline and also heads its QA department. Previously Marie held a similar position at Lysogene. Marie has been extensively involved in biotech development, NCEs and repurposed drugs with considerable interactions with the FDA, EMA and national health authorities.

Julie Warner

Vice President, Regulatory Affairs,
Alan Boyd Consultants Ltd, UK

Julie has been involved in regulatory affairs
since 2003, gaining significant pre- and
post-authorisation experience in disease
areas ranging from oncology to cardiovascular
and infectious diseases. She has a special
interest in advanced therapies, orphan drugs,
oncology, clinical trials and marketing authorisations.

zeb-younes-400-400

Zeb Younes

Head of Product Development and Regulatory Consulting, Principal Consultant, Scendea

Zeb has over 20 years’ experience in biopharmaceutical development. Zeb has experience with a range of biologics and pharmaceuticals and has authored and led preparation and review of various regulatory documentation. Zeb has over 10 years’ experience managing research teams, GMP testing laboratories and operations.

 

 

Sanna Laine

Sanna Laine Pharma Consulting AB

Sanna has more than 15 years of working experience across different regulatory areas after working within CMC, regulatory affairs, quality and safety surveillance, following her scientific career within preclinical research. Through her roles and vast network of regulatory professionals, she has gained a keen understanding of cross-functional regulatory processes, enabling her to contribute to a high-quality content of Regulatory Rapporteur.

 
 

Birgit Roser

Consultant, Regulatory Affairs, Human and Veterinary Medicine, Germany

Birgit has worked in the pharmaceutical industry since 2001, as a consultant in the field of regulatory affairs, quality assurance, GMP/GDP, clinical trials, pharmacovigilance, the medical device sector and preclinical area. She also works as a QPPV in veterinary medicine, as information manager and as an animal welfare officer. In addition to her role as a Consultant Editor on Regulatory Rapporteur’s Editorial Board, Birgit is also a member of TOPRA’s Veterinary Medicines Special Interest Group.